← FDA DRUG APPROVALS

FDA ANDA · ANDA215990

CLOBETASOL PROPIONATE ANDA

clobetasol propionate

Sponsor: MACLEODS PHARMS LTD

APPLICATION
ANDA215990
TYPE
ANDA
ORIGINAL APPROVAL
2023-12-28
LATEST ACTION
2023-12-28
ROUTE
TOPICAL
DOSAGE FORM
OINTMENT
MARKETING STATUS
Prescription

Products

CLOBETASOL PROPIONATEPrescription
CLOBETASOL PROPIONATE 0.05% · OINTMENT · TOPICAL

Approval history

2023-12-28UNKNOWN · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →